EB-2 NIW · Profession Guide
EB-2 NIW for Biomedical researchers: AAO Data, Denial Patterns & Evidence
EB-2 NIW evidence patterns for biomedical researchers: peer recognition, citation depth, and prong-three framing under Dhanasar.
Based on 6,362 real USCIS AAO decisions · Last updated May 2026
Short answer
Across 521 Biomedical Researcher AAO decisions in our corpus, 10.1% were approved on appeal, 78.5% were denied, and 11.4% were remanded. The single most common denial reason for biomedical researchers is “Weak peer recognition evidence.” AAO rates are lower than first-pass USCIS rates because these cases were already denied at least once.
AAO outcomes for biomedical researchers (521 decisions)
Read this carefully: AAO numbers reflect petitions that were already denied at least once and appealed. First-pass USCIS approval rates are substantially higher. Use these figures to understand which arguments USCIS finds insufficient at the highest scrutiny level.
Why biomedical researchers get denied at AAO
Most common AAO denial reason in this bucket:
Weak peer recognition evidence
Biomedical AAO denials repeatedly cite thin peer-recognition evidence: a long publication list with weak independent citation, or letters that read as collaborator endorsements rather than independent assessments. The decisions emphasize that "important work" is not enough; the field has to be on record reacting to it.
What strong biomedical researcher petitions tend to include
These are the evidence types that recur in approved Biomedical Researcher cases. Not every approved petition has all of them, but petitions missing several typically struggle at AAO.
- 1Independent citations to first/last-author publications, with citation context (review articles citing the work, not just one-line references)
- 2Grant funding history (R01, K-series, NIH F32, foundation grants) showing peer review at the funding stage
- 3Invitations to peer-review for journals (with acceptance emails / review reports as evidence)
- 4Editorial board roles, conference program-committee roles, study-section service
- 5Patents on translational outputs (assays, devices, therapeutic candidates)
- 6Letters from independent senior investigators at non-collaborating institutions
How biomedical researcher cases fit the Dhanasar three-prong test
The Dhanasar framework asks USCIS to evaluate three things together: substantive merit, your positioning to advance the work, and whether waiving the labor cert makes sense on balance. Here is how the prongs typically frame for biomedical researchers.
Prong 1 — Substantive merit and national importance
Tie the substantive merit to a national health priority (cancer moonshot, antimicrobial resistance, neurodegeneration, pandemic preparedness).
Prong 2 — Well-positioned to advance the proposed endeavor
Show "well-positioned" via grants secured + peer-review service — both are external validation that the field has bet on you.
Prong 3 — On balance, waiver is in the national interest
Lab continuity arguments work well here: interrupting your project under labor cert delays would forfeit grant deliverables.
What approved Biomedical Researcher profiles look like
First/last-author publications cited by independent groups, at least one externally-reviewed grant, and peer-review service for credible journals.
This is a composite based on patterns across 521 AAO decisions — not any single case. Your specific profile may clear with less, or struggle with more, depending on framing.
Run a personalized Biomedical Researcher case analysis
Aggregate data tells you what AAO has rejected for biomedical researchers. A $10 ai case review tells you which of those failure modes your profile is closest to — prong by prong, with the five most-similar AAO cases pulled directly from the same 6,362-decision corpus.
One-time payment, no subscription. Greenway AI is a data + document-generation platform, not a law firm; nothing here is legal advice.